Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Liang

Showing results (691-700 of 713) with videos related to

Pageof 72
Sort By:
Journal of Translational Medicine|February 10, 2012
Effective components screening and anti-myocardial infarction mechanism study of the Chinese medicine NSLF6 based on "system to system" modeQiong-Lin Liang, Xiao-Ping Liang, Yi-Ming Wang, et al.
Journal of Autoimmunity|May 7, 2025
Long-term outcomes of idiopathic inflammatory myopathies: a large-scale longitudinal cohort studyYiran Chen, Longyang Zhu, Chen Zong, et al.
Oncotarget|May 21, 2016
MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinomaCheng-Han Lin, Chen-Hsun Tsai, Ching-Tung Yeh, et al.
BMC Cancer|November 7, 2021
POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trialXu-Ran Zhao, Hui Fang, Yu Tang, et al.
Signal Transduction and Targeted Therapy|October 22, 2024
Systemic longitudinal immune profiling identifies proliferating Treg cells as predictors of immunotherapy benefit: biomarker analysis from the phase 3 CONTINUUM and DIPPER trialsSai-Wei Huang, Wei Jiang, Sha Xu, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 12, 2026
Conformationally Variable Peptides Trap and Detoxify Ox-LDL in Plaques for Attenuating Atherosclerosis in Multiple SpeciesHong-Mei Zhao, Jun-Ye Chen, Qi-Lin Liang, et al.
Nature Communications|February 16, 2023
TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour modelsJun-Yan Li, Yin Zhao, Sha Gong, et al.
Cancer Medicine|November 15, 2019
Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancerDe-Shen Wang, Zhi-Qiang Wang, Gong Chen, et al.
JAMA Oncology|July 14, 2022
Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in ChinaHan Qiao, Xi-Rong Tan, Hui Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2026
Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER TrialsSai-Wei Huang, Ye-Lin Liang, Ya-Lan Tao, et al.
Pageof 72

Showing results (691-700 of 713) with videos related to

Sort By:
Pageof 72
Journal of Translational Medicine|February 10, 2012
Effective components screening and anti-myocardial infarction mechanism study of the Chinese medicine NSLF6 based on "system to system" modeQiong-Lin Liang, Xiao-Ping Liang, Yi-Ming Wang, et al.
Journal of Autoimmunity|May 7, 2025
Long-term outcomes of idiopathic inflammatory myopathies: a large-scale longitudinal cohort studyYiran Chen, Longyang Zhu, Chen Zong, et al.
Oncotarget|May 21, 2016
MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinomaCheng-Han Lin, Chen-Hsun Tsai, Ching-Tung Yeh, et al.
BMC Cancer|November 7, 2021
POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trialXu-Ran Zhao, Hui Fang, Yu Tang, et al.
Signal Transduction and Targeted Therapy|October 22, 2024
Systemic longitudinal immune profiling identifies proliferating Treg cells as predictors of immunotherapy benefit: biomarker analysis from the phase 3 CONTINUUM and DIPPER trialsSai-Wei Huang, Wei Jiang, Sha Xu, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 12, 2026
Conformationally Variable Peptides Trap and Detoxify Ox-LDL in Plaques for Attenuating Atherosclerosis in Multiple SpeciesHong-Mei Zhao, Jun-Ye Chen, Qi-Lin Liang, et al.
Nature Communications|February 16, 2023
TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour modelsJun-Yan Li, Yin Zhao, Sha Gong, et al.
Cancer Medicine|November 15, 2019
Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancerDe-Shen Wang, Zhi-Qiang Wang, Gong Chen, et al.
JAMA Oncology|July 14, 2022
Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in ChinaHan Qiao, Xi-Rong Tan, Hui Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2026
Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER TrialsSai-Wei Huang, Ye-Lin Liang, Ya-Lan Tao, et al.
Pageof 72